Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Glaudemans

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Health Care Benefits|December 9, 1993
A model for regulating managed competitionJ Glaudemans
Health Affairs (Project Hope)|January 1, 1994
The case for local budgetingJ Glaudemans
Carbohydrate Research|June 1, 1989
Improved synthesis of the 2-, 3-, and 4-deoxy derivatives from methyl beta-D-galactopyranosideT H Lin, P Kovác, P J Glaudemans
Family Practice|November 9, 2014
Advance care planning in primary care, only for severely ill patients? A structured reviewJolien J Glaudemans, Eric P Moll van Charante, Dick L Willems
Family Practice|December 10, 2019
Preventing unwanted situations and gaining trust: a qualitative study of older people and families' experiences with advance care planning in the daily practice of primary careJolien J Glaudemans, Dick L Willems, Jan Wind, et al.
Family Practice|June 13, 2018
How do Dutch primary care providers overcome barriers to advance care planning with older people? A qualitative studyJolien J Glaudemans, Anja E de Jong, Bregje D Onwuteaka Philipsen, et al.
BMC Geriatrics|July 5, 2022
The patient's relationship with the General Practitioner before and after Advance Care Planning: pre/post-implementation studyAnnicka G M van der Plas, Julia E A P Schellekens, Jolien J Glaudemans, et al.
Family Practice|September 3, 2016
Interprofessional communication between oncologic specialists and general practitioners on end-of-life issues needs improvementJohn J Oosterink, Mariska G Oosterveld-Vlug, Jolien J Glaudemans, et al.
Carbohydrate Research|December 21, 2002
The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS)Ximan Liao, Emanuel Poirot, Alex H C Chang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Health Care Benefits|December 9, 1993
A model for regulating managed competitionJ Glaudemans
Health Affairs (Project Hope)|January 1, 1994
The case for local budgetingJ Glaudemans
Carbohydrate Research|June 1, 1989
Improved synthesis of the 2-, 3-, and 4-deoxy derivatives from methyl beta-D-galactopyranosideT H Lin, P Kovác, P J Glaudemans
Family Practice|November 9, 2014
Advance care planning in primary care, only for severely ill patients? A structured reviewJolien J Glaudemans, Eric P Moll van Charante, Dick L Willems
Family Practice|December 10, 2019
Preventing unwanted situations and gaining trust: a qualitative study of older people and families' experiences with advance care planning in the daily practice of primary careJolien J Glaudemans, Dick L Willems, Jan Wind, et al.
Family Practice|June 13, 2018
How do Dutch primary care providers overcome barriers to advance care planning with older people? A qualitative studyJolien J Glaudemans, Anja E de Jong, Bregje D Onwuteaka Philipsen, et al.
BMC Geriatrics|July 5, 2022
The patient's relationship with the General Practitioner before and after Advance Care Planning: pre/post-implementation studyAnnicka G M van der Plas, Julia E A P Schellekens, Jolien J Glaudemans, et al.
Family Practice|September 3, 2016
Interprofessional communication between oncologic specialists and general practitioners on end-of-life issues needs improvementJohn J Oosterink, Mariska G Oosterveld-Vlug, Jolien J Glaudemans, et al.
Carbohydrate Research|December 21, 2002
The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS)Ximan Liao, Emanuel Poirot, Alex H C Chang, et al.
Pageof 1